Cingulate Inc. Warrants (CINGW)
US$ 0.0384-14.67%
Price Chart
Key Statistics
Market Cap
$ 0
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
12.44K
52W High
$ 0.18
52W Low
$ 0.01
Dividend Yield
0.00%
Beta
-0.80
Technicals
50-Day MA
N/A
200-Day MA
N/A
52 Week High
0.18
52 Week Low
0.008
About CINGW
Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States.
Employees
13
Headquarters
Kansas City, KS
CEO
Dr. Shane J. Schaffer Pharm.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg